School of Medicine
Showing 101-150 of 410 Results
-
Cordelia Erickson-Davis
Clinical Scholar, Psychiatry and Behavioral Sciences
Postdoctoral Scholar, PsychiatryBioDr. C. Erickson-Davis is a psychiatrist and medical anthropologist specializing in the care of patients with Functional Neurological Disorder (FND), and other complex neuropsychiatric presentations. Her clinical work is grounded in a deep respect for the lived experience of illness and healing and integrates neurological, psychiatric, and sociocultural perspectives. She is committed to collaborative, trauma-informed care that honors the mind-body relationship without reduction. Her research explores the role of perception, meaning, and context in shaping symptoms and recovery, with the goal of bridging subjective experience and neurobiological models. Dr. Erickson-Davis leads the Precision Language Lab Initiative at Stanford, a space for collaborative inquiry into how lived experience, narrative, and perception can be more meaningfully integrated into the clinical neurosciences.In her clinical practice, Dr. Erickson-Davis believes in partnering closely with patients and their families to develop treatment plans that reflect their values, histories, and goals—especially in cases where conventional diagnostic categories fall short. She sees her clinical role as one of witness, translator, and advocate.
-
Neir Eshel, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioDr. Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.
His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the Stanford LGBTQ+ program.
His research interests (www.staarlab.com) include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He has won multi-year grants from the National Institutes of Health, Burroughs-Wellcome Fund, Brain and Behavior Research Foundation, and Simons Foundation to further his research.
Dr. Eshel has published articles on dopamine and motivation, the neuroscience of irritability, LGBTQ health, reward and punishment processing in depression, behavioral predictors of substance use among adolescents, and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Neuron, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and Journal of Neuroscience. He is a co-inventor on a patent pending for a new class of drugs for addiction, and also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.
He has delivered presentations on the neural circuits of motivated behavior, anger expression in patients with PTSD, how dopamine facilitates learning, and LGBTQ-related topics at departmental seminars in London, Zurich, and Tel Aviv, and at the meetings of the American College of Neuropsychopharmacology, Society of Biological Psychiatry, and Association of American Medical Colleges, among others. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Nature, Science, JAMA Psychiatry, Biological Psychiatry, and Current Biology.
Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, the Freedman Award (honorable mention) from the Brain and Behavior Research Foundation, the Polymath Award from Stanford's psychiatry department, and the National LGBT Health Achievement Award.
He is a member of the American Psychiatric Association, American College of Neuropsychopharmacology, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the chair of Stanford's LGBTQ+ Benefits Advocacy Committee.
Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University. -
Flint Espil
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Flint Espil researches the etiology and treatment of tic disorders (including Tourette’s), Obsessive-Compulsive Disorder, and body-focused repetitive behaviors. He is interested in how psychosocial factors, the environment, and underlying brain circuitry influence treatment outcomes among individuals seeking treatment. He is also exploring ways to adapt and implement evidence-based mental health approaches in community settings. He is currently collaborating with community-based organizations in East Palo Alto to improve access to care for youth in school settings.
-
Stephanie Allen Evans
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioResume visible at http://bit.ly/EvansResume
This link needs to be copied and pasted into your browser to view. -
Audrey Evers
Casual - Non-Exempt, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Psychology Doctoral Student, PGSP-Stanford PsyD Consortium
Clinical Research Coordinator, Depression Research Clinic -
Adina S. Fischer, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Caroline Fleck
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.
More information can be found on her website: https://www.drcarolinefleck.com/ -
Sai Folmsbee, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMy current research interest is the intersection of psychiatry and neuroimmunology. I am currently collaborating with Stanford Neuroimmunology in a retrospective analysis of patient data to determine the relationship between psychaitric medications and clinical outcomes in hospitalized patients with mutliple sclerosis, autoimmune encephalitis, and neuromyelitis optica.
-
Katie Fracalanza, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Fracalanza is interested in factors underlying the development and maintenance of mood and anxiety disorders. She has conducted research on cognitive factors thought to maintain anxiety, such as intolerance of uncertainty and perfectionism. She is interested in the patient perspective, and conducting research from a qualitative lens to better understand this.
-
George Mark Freeman MD PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Freeman serves as the Site Director for Stanford Psychiatry Residency Training at VA Palo Alto Hospital. His interests include caring for patients with complex mental health conditions, providing medical education to Stanford trainees, and remaining up to date on the latest in neuroscience advances.
EDUCATION
B.S. Biology (Neuroscience), Duke University
M.D. Medical Scientist Training Program, Washington University in St Louis
Ph.D. In Biological and Biomedical Sciences (Neuroscience), Washington University in St Louis
RESIDENCY TRAINING
Psychiatry Residency (Research Track), Stanford University School of Medicine, Stanford, CA
LICENSURE AND CERTIFICATION
Diplomate, General Psychiatry, American Board of Psychiatry and Neurology
Physician and Surgeon Medical License, California
SELECTED SCHOLARSHIPS AND HONORS
National Institute of Mental Health (NIMH) Outstanding Resident Award
James L. O’Leary Prize for Research in Neuroscience Finalist
Ruth L Kirschstein National Research Service Award
United States Fulbright Scholar -
Julia Alexsandra Galiza Soares
Life Sciences Researcher 1, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordREACH Postbac Scholar, Life Science Research Professional I
-
Giancarlo Glick
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.
-
Christine E. Gould
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Gould received her Ph.D in psychology from West Virginia University. She completed her internship at VA Palo Alto Health Care System and an Advanced Fellowship in Geriatrics at the GRECC. Dr. Gould is board certified in geropsychology. Her research program develops and tests tailored, self-directed mental health interventions in older adults. Her current funded studies are testing the efficacy of a video-delivered progressive muscle relaxation program with telephone coaching support in reducing anxiety and improving functioning and examining the use of technology by older Veterans. She is also is examining a mobile app-based intervention for depression in middle age and older adults. Dr. Gould has an active interest in training future geriatric mental health clinicians and researchers. She provides mentorship in the following areas: geriatric mental health interventions, technology-delivered interventions for older adults, program evaluation/quality improvement, and qualitative research methods.
-
Carlos Greaves
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBorn and raised in Caracas, Venezuela. Medical school at the Central University School of Medicine, where Internship was completed.
Residency training at Stanford Medical School, Department of Psychiatry. Work in Community Mental health in Maui, Hawaii for 4 years.
Work at the Veterans Administration in Palo Alto for 3 years. Currently in Private Practice and as consulting psychiatrist at the Vaden Student Health center at Stanford -
Benjamin Daniel Greenberg
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Greenberg provides direct psychological care to patients in the ADAPT (Adult Depression and Anxiety Psychological Treatment) & Dual Diagnosis clinics. He is passionate about delivering evidence-based psychotherapies that are responsive and personal. He conducts individual as well as group therapy.
He teaches a psychotherapy didactic to the Addiction Medicine fellows as well as provides clinical supervision to post-doctoral fellows, doctoral students, and psychiatry residents. He is committed to helping trainees learn & work through complex situations that arise in individual & group psychotherapy. -
Nancy A. Haug
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PGSP-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.
Dr. Haug is a member of the American Psychological Association (APA) Ethics Committee and formerly served as a member of the California Psychological Association Ethics Committee. She is a Fellow and Member-at-Large for Practice in the Society of Addiction Psychology (APA, Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.
Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She recently completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis. -
Chris Hayward
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsDr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.
-
John P. Hegarty II
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.
My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism. -
Boris Heifets
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology (Adult))
Current Research and Scholarly InterestsHarnessing synaptic plasticity to treat neuropsychiatric disease
